Skip to main content
DSM
NYSE Unknown

BNY Mellon Fund Fights Activist, Offers Fee Cuts in Proxy Battle

Analysis by Wiseek AI
Sentiment info
Neutral
Importance info
8
Price
$6.1
Mkt Cap
0
52W Low
$5.445
52W High
$6.3
Market data snapshot near publication time

Summary

BNY Mellon Strategic Municipal Bond Fund is actively soliciting shareholder votes for its current board nominees, offering fee and distribution cuts in an ongoing proxy battle against activist investor Saba Capital Management.


Key Events

  • Contested Board Election

    The fund is actively soliciting votes for its board-recommended nominees (Roslyn M. Watson, Joan L. Gulley, and Burton N. Wallack) in an ongoing proxy battle against activist investor Saba Capital Management.

  • Fee and Distribution Concessions

    The board highlights an agreement to lower fund distributions and waive a $0.030 portion of the investment adviser's fee through May 31, 2027, aimed at reducing expenses for shareholders.

  • Defense of Current Strategy

    The filing emphasizes the fund's consistent income delivery and outperformance against peers on a net asset value (NAV) and market return basis, urging shareholders to protect their investment from Saba Capital.

  • Activist Opposition

    Shareholders are explicitly advised to disregard any 'GOLD proxy card' received from Saba Capital Management, which has nominated its own individual to the Fund's Board.


Analysis

This filing is a direct appeal from the current board to shareholders, defending its nominees against activist investor Saba Capital Management. The board is making concessions, including lower distributions and fees, to retain control. The outcome of this contested election could significantly impact the fund's management, fee structure, and overall strategy, making it a critical governance event for investors.

At the time of this filing, DSM was trading at $6.10 on NYSE in the Unknown sector. The 52-week trading range was $5.45 to $6.30. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

DSM - Latest Insights

DSM
Jun 03, 2026, 5:35 PM EDT
Filing Type: DEFA14A
Importance Score:
8
DSM
May 18, 2026, 4:25 PM EDT
Filing Type: DEFA14A
Importance Score:
8
DSM
May 07, 2026, 10:00 AM EDT
Filing Type: DFAN14A
Importance Score:
9
DSM
May 06, 2026, 3:42 PM EDT
Filing Type: DEFA14A
Importance Score:
7
DSM
Apr 29, 2026, 3:45 PM EDT
Filing Type: DEFC14A
Importance Score:
8
DSM
Apr 16, 2026, 1:20 PM EDT
Filing Type: PREC14A
Importance Score:
8
DSM
Apr 14, 2026, 6:04 PM EDT
Filing Type: PREC14A
Importance Score:
8